(C) PLOS One [1]. This unaltered content originally appeared in journals.plosone.org.
Licensed under Creative Commons Attribution (CC BY) license.
url:https://journals.plos.org/plosone/s/licenses-and-copyright

------------



The novel ORFV protein ORFV113 activates LPA-p38 signaling

['Sushil Khatiwada', 'Department Of Pathobiology', 'College Of Veterinary Medicine', 'University Of Illinois At Urbana-Champaign', 'Urbana', 'Illinois', 'United States Of America', 'Gustavo Delhon', 'School Of Veterinary Medicine', 'Biomedical Sciences']

Date: 2021-11

Viruses have evolved mechanisms to subvert critical cellular signaling pathways that regulate a wide range of cellular functions, including cell differentiation, proliferation and chemotaxis, and innate immune responses. Here, we describe a novel ORFV protein, ORFV113, that interacts with the G protein-coupled receptor Lysophosphatidic acid receptor 1 (LPA 1 ). Consistent with its interaction with LPA 1 , ORFV113 enhances p38 kinase phosphorylation in ORFV infected cells in vitro and in vivo, and in cells transiently expressing ORFV113 or treated with soluble ORFV113. Infection of cells with virus lacking ORFV113 (OV-IA82Δ113) significantly decreased p38 phosphorylation and viral plaque size. Infection of cells with ORFV in the presence of a p38 kinase inhibitor markedly diminished ORFV replication, highlighting importance of p38 signaling during ORFV infection. ORFV113 enhancement of p38 activation was prevented in cells in which LPA 1 expression was knocked down and in cells treated with LPA 1 inhibitor. Infection of sheep with OV-IA82Δ113 led to a strikingly attenuated disease phenotype, indicating that ORFV113 is a major virulence determinant in the natural host. Notably, ORFV113 represents the first viral protein that modulates p38 signaling via interaction with LPA 1 receptor.

Viruses have evolved mechanisms to subvert critical cellular signaling pathways that regulate diverse cellular functions. LPA signaling in skin is known to affect a wide range of cellular functions, including cell differentiation, migration, proliferation and chemotaxis, and it has been implicated in innate immune responses, inflammation and wound healing. Here, we show that ORFV113, a protein unique to parapoxviruses, interacts with the G protein coupled receptor, Lysophosphatidic acid receptor 1 (LPA 1 ) enhancing p38 phosphorylation in ORFV-infected cells in vitro and keratinocytes in vivo, and in cells transiently expressing ORFV113 or treated with soluble ORFV113. p38 signaling markedly affects ORFV plaque formation and replication in infected cells. When ORFV113 is deleted from the viral genome, the resulting virus loses the ability to replicate to high titers and to induce gross lesions in the skin of sheep. Notably, ORFV113 represents the first viral protein that modulates p38 signaling by interacting with LPA 1 receptor.

Funding: This work was supported by Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture ( https://nifa.usda.gov/ ) award number 2020-67015-31300 (DLR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Copyright: © 2021 Khatiwada et al. This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Here, we show that ORFV113, a protein unique to parapoxviruses, enhances p38 phosphorylation in ORFV-infected cells in vitro and keratinocytes in vivo, and in cells transiently expressing ORFV113 or treated with soluble ORFV113. p38 signaling markedly affects ORFV plaque formation and replication in infected cells. We found that ORFV113 interacts with LPA 1 receptor, which is involved in ORFV113-mediated enhancement of p38 activation. When ORFV113 is deleted from the viral genome, the resulting virus loses the ability to replicate to high titers and to induce gross lesions in the skin of sheep. Notably, ORFV113 represents the first viral protein that modulates p38 signaling by interacting with LPA 1 receptor.

While modulation of LPA signaling by viral factors has not been described, a few modulators of p38 signaling have been reported. For example, vaccinia virus protein A52R, known to inhibit IL-1- and Toll-like receptor-stimulated NF-κB activation, was found to activate p38 MAPK in a TRAF6 dependent manner [ 39 , 40 ]. E3, a vaccinia virus double-stranded RNA binding protein that inhibits cytokine expression, suppressed p38 phosphorylation in vaccinia virus-infected cells via an unknown mechanism [ 41 ].

Many viruses hijack G-protein-coupled receptors to ensure viral replicative success and often contribute to their pathogenesis. However, no direct role for LPA signaling in the context of virus infection has been reported. A recent study identified a pro-viral role of LPA signaling during Hepatitis C virus infection [ 38 ]. Hepatitis C virus replication was shown to induce expression of autotaxin (ATX) which activates LPA signaling by hydrolyzing lysophosphatidylcholine (LPC) to lysophosphatidic acid (LPA). Inhibition of ATX-LPA signaling decreased hepatitis C virus replication in hepatocytes.

Lysophosphatidic acid (LPA), is an ubiquitously expressed, short lived phospholipid mediator that signals through six different G-protein-coupled receptors (LPA 1 -LPA 6 ) [ 20 ]. LPA signaling affects cell differentiation, proliferation, cytokine and chemokine secretion, cell migration and chemotaxis, and has been implicated in inflammation, cancer, wound healing and development [ 21 – 25 ]. LPA is produced either from lysophospholipids by the plasma enzyme, autotaxin (ATX/ENPP2) or from phosphatidic acid by activity of phospholipase A1 (PLA1) or phospholipase A2 (PLA2), and is found intra-and extracellularly [ 26 – 28 ]. LPA 1 , the most important of six LPA receptors, can bind to different G-protein α subunits, namely Gα12/13, Gαq11 and Gαi/o, to transduce Rho, Phospholipase C, MAP kinase (MAPK) and AKT signaling, respectively [ 20 , 23 ]. MAP kinases are part of the signaling cascade that respond to extracellular stimuli and comprises four discrete sub-groups, (1) extracellular signal-regulated kinases (ERKs), (2) c-jun N-terminal or stress-activated protein kinases (JNK/SAPK), (3) big MAP kinase 1 (BMK1), and (4) the p38 group of protein kinases [ 29 ]. p38 kinases consists of four different splice variants namely p38α, p38β, p38γ and p38δ. Of these, p38α and p38β are ubiquitously expressed while p38γ and p38δ are differentially expressed depending on the tissue type [ 30 ]. Treatment of cells with LPA induces upregulation of chemokines/cytokines such as interleukin-6 and interleukin-8 (IL-8) through activation of various signaling pathways including p38 MAPK, p42/44 MAPK, and Rho kinase [ 31 ]. In various cell types, including oral keratinocytes, LPA induced p38 MAPK activation leading to the transcription of IL-8 [ 32 – 35 ]. In rat aortic smooth muscle cells and human hepatocellular carcinoma (HCC) cell lines, LPA induces p38 activation leading to migration of cells and invasiveness, respectively [ 36 , 37 ].

Based on sequence homology to host and viral genes, ORFV genes with putative immunomodulatory functions have been identified, including genes encoding IL-10-like protein (ORV127) [ 9 ], chemokine binding protein (ORV112) [ 10 ], vascular endothelial growth factor (VEGF) (ORV132) [ 11 ], granulocyte macrophage colony stimulating factor (GM-CSF) and IL-2-inhibitory factor or GIF (ORV117) [ 12 ], apoptosis inhibitor (ORV125) [ 13 ], and IFN resistance protein (ORV020) [ 14 ]. Five genes (ORFV-002, -024, -073, -119, and -121) were shown to encode novel NF-κB inhibitors [ 15 – 19 ].

ORFV is the type member of the Parapoxvirus genus of Poxviridae, which also includes bovine pathogens pseudocowpox virus (PCPV) and Bovine papular stomatitis virus (BPSV), red deerpox virus, and Grey sealpox virus. The ORFV genome is approximately 138 kbp in length, and encodes for 132 genes [ 6 ]. The central genomic region contains genes highly conserved among the poxviruses that are essential for virus replication and structure, while the terminal genomic regions contains less conserved genes involved in virulence, and host range and immunomodulation [ 6 ]. The later genes are usually not essential for virus replication in cultured cells, but they affect virus virulence and pathogenesis in the host, and might play a role in viral persistence [ 7 , 8 ].

Orf or contagious ecthyma is a ubiquitous, highly contagious disease of sheep and goats caused by orf virus (ORFV). The disease is characterized by lesions at mucocutaneous margins in the mouth, reflecting virus tropism for keratinocytes [ 1 ]. Lesions progress from maculae to papulae, pustules and scabs, and usually resolve in 6–8 weeks [ 2 ]. The disease is usually mild and lesions remain confined to virus entry sites [ 3 ] and, although viremia has not been associated with ORFV infection, recently virus has been detected in blood of asymptomatic animals [ 4 ]. ORFV infection in sheep induces a potent early inflammatory response followed by a T-helper type 1 immune response at later stages. However, protective immunity against orf is short lived and virus can reinfect the host in both natural and experimental infections [ 5 ].

For sequence analysis, PPV113 amino acid sequences were aligned using Clustal Omega (EMBL-EBI). ORFV113 GeneBank accession numbers are (virus strains in parentheses) AAR98208.1 (OV-IA82), ABA00631.1 (NZ2), AHH34298.1 (B029), ADY76833.1 (D1701), NP_957890.1 (OV-SA00), AKU76735.1 (OV-GO), AKU76603.1 (OV-YX), AHZ33811.1 (NA1/11), AKU76867.1 (NP), AYM26054.1 (NA17), AYN61061.1 (SY17) and AKU76991.1 (OV-SJ1). PCPV113 and BPSV113 GeneBank accession numbers are ADC53885.1 (PCPV F00-120R), YP_003457420.1 (PCPV VR634) AEO18263.1 (PCPV IT1303/05), NP_958022.1 (BPSV BV-AR02), AKC03539.1 (BPSV BV-TX09c1) and AKC03281.1 (BPSV BV-TX09c15). Accession numbers for PPV113 of Parapoxvirus red deer strain HL953 and seal parapoxvirus strain AFK76s1 are YP_009112855.1 and YP_009389398.1, respectively.

Antigen retrieval was performed on deparaffinized tissue sections using Citrate solution (Electron Microscopy Sciences; 50-192-6525) and following manufacturer’s instructions. Sections were permeabilized, blocked, incubated with primary antibody against HA (Cell Signaling Technology; 3724 and 2367), GFP (Thermo Fisher Scientific; A-11122 and A11120), LPA 1 (Novus Biologicals; NBP1-03363), phos-p38 (Cell Signaling Technology; 4511) or IL-8 (Santa Cruz Biotechnology; sc-376750), and with appropriate Alexa fluor 488 and 647 labeled secondary antibodies, counterstained with DAPI, mounted with Prolong antifade reagent (Thermo Fisher Scientific; P10144) and examined by confocal microscopy.

To evaluate the effect of ORFV113 on ORFV virulence in the natural host, 66–80 lb. lambs were randomly allocated to three experimental groups, deletion mutant virus OV-IA82Δ113 (n = 4; sheep 5, 11, 55 and 130), revertant virus OV-IA82RV113 HA (n = 4; sheep 15, 40, 93 and 430) and mock (n = 3; sheep 25, 38 and 81). Following general anesthesia with ketamine/midazolam, the mucocutaneous junction of the lip near the right labial commissure and the inner sides of the hind limbs were scarified along 2 cm and 5 cm-long lines, respectively. Five hundred μl of virus inoculum (10 7.5 TCID 50 /ml; virus groups) or PBS (control group) were then applied topically to each site using cotton swabs. The scarified areas of the lips were monitored for 20 days for the presence of characteristic orf lesions, including erythema, papules, pustules, and attached scab. Skin biopsy specimens were collected from hind limb inoculation sites at 1 day (d), 2 d, 3 d, and 7 d. p.i., fixed in 10% buffered formalin, and processed following standard histology procedures. To quantify the viral load, skin biopsies were frozen and thawed three times, sonicated, and viral titers determined as described above.

To investigate the effect of LPA on ORFV113-induced p38 signaling, phosphorylation of p38 was assessed by Western Blot. OFTu cells transfected with pEmpty HA or pORFV113 HA plasmids for 5 h, were induced with LPA for 5, 10 and 20 min, and harvested. Total cell protein extracts (50 μg) were resolved by SDS-PAGE, and bands were blotted as above. Blots were incubated with antibodies against phos-p38, total p38 and HA. Blots were processed and protein bands were quantified as described above.

KI16425, a widely used LPA 1 inhibitor was used to investigate the role of LPA 1 on ORFV113-induced p38 phosphorylation [ 47 – 49 ]. OFTu cells were pretreated with DMSO (vehicle control) or KI16425 (10 μM) for 45 min and were then treated with immunoprecipitation products from pCMV-HA or pORFV113 HA expressing cells in the presence of DMSO or KI16425 and harvested at 1 h and 3 h post treatment. Total cell protein extracts were resolved by SDS-PAGE, blotted and incubated with antibodies against phos-p38 and total p38. Blots were processed and protein bands were quantified as described above.

To assess the effect of antibody against LPA 1 on ORFV113 induced p38 phosphorylation, OFTu cells pretreated with IgG 2a mouse isotype control (Thermo Fisher; 026200) or LPA 1 mouse monoclonal antibody (sc-515665;Santa cruz) (10 μg/ml) for 45 min were treated with immunoprecipitation products from pCMV-HA or pORFV113 HA expressing cells in presence of isotype control or LPA 1 monoclonal antibody (10 μg/ml) and harvested at 1 h and 3 h post treatment.

To examine the effect of LPA 1 knock down on ORFV113 induced p38 activation, wildtype and CRISPR knockdown OFTu cells cultured for 16 h were either harvested for assessing LPA 1 knockdown or treated with immunoprecipitation products from pCMV-HA or pORFV113 HA expressing cells and harvested at 1 and 3 h post treatment. Level of LPA 1 knockdown and effect of LPA 1 knockdown on ORFV113 induced p38 activation were examined using western blot and densitometric analysis of bands as described above.

To construct CRISPR LPA 1 knockdown cells, OFTu cells were co-transfected with LPA 1 CRISPR knock out plasmid and homology directed repair plasmid consisting of Puromycin drug resistance and RFP cassette (Santa Cruz) using Lipofectamine 2000 for 24h. Selection, amplification and maintenance of the culture were performed in the presence of Puromycin dihydrochloride (3μg/ml; Santa Cruz) and monitored by fluorescence microscopy. LPA 1 knockdown was measured by western blot using LPA 1 antibody (Santa Cruz; B-10).

To examine the role of LPA 1 on ORFV113-induced phosphorylation, LPA 1 expression was downregulated using siRNAs. OFTu cells were transfected with universal negative control siRNA (SIC001, Sigma Aldrich) or with three pooled siRNAs directed against sheep LPA 1 1-LPA 1 -(S): CCTACTTCTACCTAATGTT, LPA 1 -(AS): AACATTAGGTAGAAGTAGG; 2-LPA 1 -(S): CCCAATACTCGGAGACTGA, LPA 1 -(AS): TCAGTCTCCGAGTATTGGG; 3-LPA 1 -(S): GGTGGTTCTGTATGCTCAT, LPA 1 -(AS): ATGAGCATACAGAACCACC (Custom Oligos: Sigma Aldrich) (100 nM) for 24 h using Mission siRNA transfection reagent (S1452, Sigma Aldrich) and then either harvested for assessing LPA 1 knockdown or treated with immunoprecipitation products from pCMV-HA or pORFV113 HA expressing cells and harvested at 1 h and 3 h post treatment. To measure the LPA 1 knockdown, total cell protein extracts were resolved by SDS-PAGE, blotted and incubated with antibodies against LPA 1 and GAPDH. Densitometry of LPA 1 bands were normalized to the loading control GAPDH. Fold changes were calculated relative to universal negative control siRNA treatment. To assess the effect of LPA 1 knockdown on ORFV113 induced p38 activation, total cell protein extracts were resolved by SDS-PAGE, blotted and incubated with antibodies against phos-p38 and total p38. Blots were processed and protein bands were quantified as described above.

To investigate the effect of the ORFV113 protein on p38 phosphorylation, OFTu cells were treated with 60 μl of empty HA or ORFV113 HA immunoprecipitation product for 1 h and 3 h. Total cell protein extracts (50 μg) were resolved by SDS-PAGE, blotted and incubated with antibodies against phos-p38 and total p38. Blots were processed and protein bands were quantified as described above.

OFTu cells transfected with pCMV-HA (Empty HA plasmid) or pCMV-ORFV113 HA (ORFV113 HA plasmid) (2 μg) were harvested 24 h post transfection and whole cell proteins were extracted using mammalian protein extraction reagent (Thermo Fisher, Waltham, MA). Immunoprecipitation was performed following manufacturer’s protocols. Whole cell extracts were added to 40 μl pre-washed anti-HA antibody conjugated agarose (Thermo Fisher; PI26181) and incubated overnight at 4°C. Beads were washed four times with 1X Tris buffered saline containing 0.05% Tween and protein was eluted with 130 μl anti-HA peptide (Thermo Fisher; PI26184). Presence of ORFV113 HA in immunoprecipitated product was assessed by western blot using antibody against HA as described above.

To investigate the effect of ORFV113 on p38-regulated gene expression, OFTU and HFF1 cells were transfected with pCMV-HA (Empty HA plasmid) or pCMV-ORFV113 HA (ORFV113 HA plasmid) (2 μg) for 1, 2 and 3h and for 6h. RNA was extracted using Zymo Direct-Zol RNA extraction kit (Zymo, Cat # 74104) and reverse transcribed as previously described [ 15 ]. The expression of interleukin-8 (IL-8) gene was assessed using Custom Plus TaqMan Gene Expression Assays (Applied Biosystems) based on ovine gene sequences in GenBank. Real-time PCR were performed as previously described [ 15 ]. Experiments were conducted with biological and technical triplicates. Results were expressed as fold changes relative to empty HA plasmid treatment.

To investigate the potential effect of ORFV113 present in cell culture supernatant on p38 signaling, OFTu cells were treated with clarified culture supernatants harvested from OFTu cells transfected with pCMV-HA (Empty HA plasmid), pCMV-ORFV113 HA (ORFV113 HA plasmid) or pCMV-ORFV113 (Untagged ORFV113 plasmid) for 3 h. Total cell extracts were prepared and p38 phosphorylation was assessed by Western blot and analysed as described above.

To investigate the effect of ORFV113 on p38 phosphorylation, HFF1 cells untreated, UV treated or transfected with pCMV-HA (Empty HA plasmid), or pCMV-ORFV113 HA (ORFV113 HA plasmid) (2 μg) were harvested at 2, 4 and 6 h post transfection. Total cell protein extracts (50 μg) were resolved by SDS-PAGE, blotted and incubated with antibodies against phos-p38, total p38, HA and GAPDH. Blots were processed and protein bands were quantified as described above.

To assess the effect of p38 inhibition on ORFV replication, OFTU cell pretreated with vehicle control (DMSO) or inhibitor SB203580 for 1 h were infected with OV-IA82 or OV-IA82Δ113 (MOI:0.1) in presence of DMSO or SB203580, and harvested at various time points, and virus titers determined in OFTu cells and expressed as TCID 50 /ml.

SB203580, a widely used p38 inhibitor, was selected to investigate the effect of p38 inhibition on ORFV replication and plaque size formation [ 44 – 46 ]. OFTu cells were pretreated with vehicle control (DMSO) or inhibitor SB203580 (10 μM) for 1 h and then infected with OV-IA82Δ113 (GFP reporter) or OV-IA82RV113 (RFP reporter). Plaque assays were performed in presence of DMSO or SB203580, and fluorescent plaques imaged at 5 days p.i.

To investigate the effect of ORFV113 on MAP kinase (MAPK) p38 signaling during ORFV infection. OFTu cells were mock-infected or infected with OV-IA82, OV-IA82-Δ113, OV-IA82-RV113 HA (ORFV113 with HA tag) or OV-IA82-RV113 (ORFV113 untagged) (MOI, 10) for 1, 3, 5, 12 or 24 h p.i. Total cell protein extracts were resolved by SDS-PAGE, blotted and incubated with antibodies against phos-p38 (Cell Signaling Technology; 4511) and total p38 (Cell Signaling Technology; 8690). Blots were processed as described above. Protein bands were quantified by densitometric analysis using ImageJ software, Version 1.6.0 (National Institute of Health, Bethesda, MD). Densitometry of phos-p38 bands were normalized to the loading control total p38.

To investigate the cellular localization of ORFV113 and LPA 1 , OFTU cells mock infected or infected with OV-IA82RV113 HA for 24 h were fixed with 4% paraformaldehyde, sequentially incubated with primary antibodies against HA and LPA 1 (Novus Biologicals; NBP1-03363), and secondary antibodies labeled with Alexa fluor 488 and 647, counterstained with DAPI, and examined by confocal microscopy.

To investigate the potential interaction of ORFV113 with LPA 1 , OFTu cells co-transfected with pcDNA3.1 His and pCMV Flag or pCMV HA (control plasmids) or pcDNA3.1-LPA 1 His (pLPA 1 His ) and pCMV-ORFV113 Flag (p113 Flag ) or pCMV-CD2v HA (pCD2v HA ) (plasmid with African swine fever virus membrane protein CD2v used as a specificity control) (1 μg) were harvested 24 h post transfection and membrane extracts were prepared using membrane protein extraction reagent (Thermo Fisher, Waltham, MA). Co-immunoprecipitation was performed on membrane protein extracts with antibodies against His (Genscript; A00186), Flag and HA (Cell Signaling Technology; 3724) as described above. Bound proteins were eluted from beads in 2X Laemmli buffer, resolved by SDS-PAGE, blotted to nitrocellulose membranes, probed with antibodies against His, Flag and HA (Cell Signaling Technology; 2367) and developed as described above.

To prepare ORFV113-immunoprecipitation sample for mass spectrometry analysis of cellular interacting partners, OFTu cells was transfected with plasmid pCMV-ORFV113 Flag for 24 h and total cell protein was extracted as described above. Co-immunoprecipitation was performed using Active Motif Co-IP Kit (Active Motif, Carslbad, CA) following manufacturer’s protocols. Extracts were co-immunoprecipitated with anti-Flag antibody overnight at 4°C, and then incubated with 50 μl of pre-washed protein G agarose beads (Cat. #16–266; Millipore) at 4°C for 2 h. Beads were washed four times with high stringency buffer and bound proteins eluted in 1X Laemmli buffer. LC-MS Mass Spectrometry and data analysis were performed by Protein Sciences Facility, Roy J. Carver Biotechnology Center, UIUC. For data analysis, Xcalibur raw files were converted by Mascot Distiller into peak lists submitted to an in-house Mascot Server and searched against specific NCBI-NR protein databases, Thermo Proteome Discover, MaxQuant and GeneOntology modules.

To assess the effect of ORFV113 on plaque formation, OFTu cells in 6-well plates were infected with OV-IA82Δ113 (GFP reporter) or OV-IA82-RV113 Flag (RFP reporter) (10 −5 dilution of virus stock) for 1 h and cultures were washed three times with MEM media. Cultures were then overlaid with 2X MEM (MEM, 10% FBS, sodium bicarbonate, penicillin-streptomycin, Gentamycin and L-Glutamine) mixed with equal volume of 1% agarose. At 5 days post infection, random plaques (n = ~100) were imaged for each treatment and plaque area measured using Nikon A1 software.

The replication characteristics of OV-IA82Δ113 was assessed in OFTu cells. Cells cultured in 12-well plates were infected with OV-IA82, OV-IA82Δ113 or OV-IA82-RV113 Flag using MOI 0.1 and 0.01 (multi-step growth curves) or 10 (single-step growth curve) and harvested at 6, 12, 24, 36, 48 and/or 60, 72, 84, 96 and 120 h p.i. Virus titers at each time point were determined as described above.

The presence of ORFV113 was examined in supernatants of OFTu cells transfected with pCMV-HA (Empty HA plasmid), pCMV-ORFV113 HA (ORFV113 HA plasmid) or pCMV-ORFV113 (Untagged ORFV113 plasmid) (2 μg). Culture supernatants were harvested 24 h post transfection and clarified by centrifugation at 2000 rpm for 10 min. Fifty μl of clarified culture supernatants were resolved by SDS-PAGE, blotted and incubated with antibodies against HA.

To check for the presence of ORFV113 in supernatant of ORFV infected cultures, OFTu cells were mock infected or infected with OV-IA82-Δ113 or OV-IA82-RV113 HA (MOI, 10) and culture supernatants were harvested at 24 h p.i. Cellular debris and virions were removed from supernatants by centrifugation at 2000 rpm for 10 min and of the virus by ultracentrifugation at 25,000 rpm for 1 h, respectively. Immunoprecipitation (see below) was performed on clarified supernatants using HA antibody (Cell signaling; 3724) and immunoprecipitation products were resolved by SDS-PAGE, blotted and incubated with antibody against HA (Cell signaling; 2367). Blots were processed as described above.

To assess the subcellular localization of ORFV113, OFTu cells (1.5 x 10 5 cells/well) were cultured in four-well chamber slides (ibidi, Martinsried, Germany) for 16 h and mock infected or infected with OV-IA82-RV113 HA (MOI, 10). Cells were fixed at 1, 3, 6, 9, 12 or 24 h p.i. with 4% paraformaldehyde for 20 min, unpermeabilized or permeabilized with 0.2% Triton X 100 for 10 min, blocked with 1% bovine serum albumin (Sigma-Aldrich, St. Louis, MO) for 1 h, and incubated with primary antibody against HA overnight at 4°C. Cells were then incubated with Alexa fluor 488 labelled secondary antibody (Thermo Fisher Scientific; A-11005), counterstained with DAPI (2 μg/ml) for 10 min and visualized by confocal microscopy (A1, Nikon).

The transcription kinetics of ORFV113 during ORFV infection in OFTu cells was examined by RT-PCR following procedures previously described [ 16 ]. Transcription of ORFV113, ORFV055 (late gene control) and ORFV119 (early gene control) was assessed by PCR using the primers 113intFw-5’-CGCCGTAATATGCTTAACCGGAGC-3’ and 113intRv-5’-CGGACCGTGTTGGTCGTTGGGTCT-3, 055LFw-5′-AATCATGGATCCGCCACCATGTTCTTCGCGCGTCGC-3′, and 055LRv-5′-TATCATCTCGAGCGGGCGTGGAGGTCGCCGAC C-3′ and 119intFw-5’-CTCTCGTAGGCTCGCTCTTG-3’ and 119EintRv-5’-GTCTCGAAGCA CCAGAGGTC-3’ respectively.

To evaluate ORFV113 expression during virus infection, OFTu cells were mock infected or infected with OV-IA82-RV113 Flag (MOI, 10) for 1, 2, 4, 6, 8, 12 or 24 h p.i. Total protein extracts (50 μg) were resolved by SDS-PAGE or native PAGE, blotted and transferred to nitrocellulose membranes, and probed with primary antibody against Flag and GAPDH. Blots were then incubated with appropriate HRP-labeled secondary antibodies and developed using chemiluminescent reagents.

Intracellular mature virus (IMV) from OFTu cells infected with OV-IA82-Δ113 or OV-IA82-RV113 Flag was purified using double sucrose gradient protocol as previously described [ 19 ]. Whole cell extracts (50 μg) from OV-IA82-RV113 Flag infected OFTu cells, and purified IMV virions (10 μg) were resolved by SDS-PAGE, blotted to nitrocellulose membranes and probed with primary antibodies against Flag (Genscript; A00187), ORFV structural protein ORFV086 or host Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) (Santa Cruz; sc-25778) overnight at 4°C [ 43 ]. Blots were incubated with the appropriate HRP-labeled secondary antibodies (1:15,000, anti-mouse, sc-2031 and anti-rabbit, sc-2004; Santa Cruz, respectively) and membranes were developed using chemiluminescent reagents (SuperSignal West Femto, Thermo Fischer Scientific).

OFTu cells infected with OV-IA82, OV-IA82-Δ113, OV-IA82-RV113 Flag , OV-IA82-RV113 HA or OV-IA82-RV113 (MOI, 0.1) were harvested at three days post infection (p.i.) and disrupted by three cycles of freeze and thaw. Cellular debris were removed by centrifugation at 1500 rpm for 5 min, and virus pelleted by ultracentrifugation at 25,000 rpm for 1 h. Pellets were resuspended in MEM, and pelleted again by ultracentrifugation, resuspended in MEM, aliquoted and frozen at -80°C. Viral titers were obtained in OFTu cells by the Spearman-Karber’s 50% tissue culture infectious dose (TCID 50 ) method.

To obtain OV-IA82-Δ113, OFTu cells were infected with OV-IA82 using a multiplicity of infection (MOI) of 1 and transfected with recombination plasmid pΔ113-GFP. To obtain the revertant viruses OV-IA82-RV113 Flag , OV-IA82-RV113 HA and OV-IA82-RV113, OFTu cells were infected with OV-IA82-Δ113 (MOI, 1) and transfected with the respective recombination plasmids. Recombinant viruses were isolated by limiting dilution and plaque assay using fluorescence microscopy as previously described [ 16 ]. Identity and integrity of viral DNA sequences were confirmed by PCR and DNA sequencing.

To generate gene deletion mutant virus OV-IA82-Δ113, a recombination cassette (pΔ113-GFP) containing vaccinia virus 7.5 early-late promoter (VV7.5)-driven green fluorescent protein (GFP) gene flanked by ORFV113 left and right flanking regions was constructed as previously described [ 42 ]. To generate revertant viruses OV-IA82-RV113 Flag , sequences were synthesized containing C-terminally Flag tagged ORFV113 and a red fluorescent protein (RFP) reporter gene, all flanked by approximately 600 bp of homologous sequence on either side to mediate recombination (Genscript, Piscataway, NJ). To generate revertant viruses OV-IA82-RV113 HA (ORFV113 with HA tag) and OV-IA82-RV113 (untagged ORFV113), recombination plasmids containing ORFV113 sequence containing C-terminal HA tag or untagged ORFV113 and VV7.5-driven RFP reporter gene flanked by ORFV113 left and right flanking regions were constructed.

To construct expression plasmids pORFV113 Flag , ORFV113 coding sequences were PCR-amplified from the OV-IA82 genome with primers 113-3xFlag-FW (EcoRI): 5’- TAAGGCCTCTGAATTCAATGGAAGTGTTGGTGATCGTCTC-3’;113-3xFlag-RV (BamHI): 5’-CAGAATACGTGGATCCCTACTCGTCGTAGAAAAACTCTCC-3’ and cloned into p3xFlag-CMV-10 vector (pFlag) and (Clontech, Mountain View, CA). Similarly, to obtain a ORFV113-HA (pORFV113 HA ) and untagged ORFV113 (pORFV113) expression vectors, ORFV113 sequence was PCR amplified from OV-IA82 genome with primers 113-HA-FW (EcoRI): 5’-TAAGGCCTCTGAATTCGCCACCATGGAAGTGTTGGTGATCGTCTC-3’ and 113-HA-RV (KpnI): 5’-CAGAATACGTGGTACCCTCGTCGTAGAAAAACTCTCCCT-3’ and, UN113-FW (EcoRI): 5’-TAAGGCCTCTGAATTCGCCACCATGGAAGTGTTGGTGATC GTCTC-3’ and UN113-RV (KpnI): 5’-CAGAATACGTGGTACCCTACTCGTCGTAGAA AAACTCTCCCT-3’, and cloned into the vector pCMV-HA-C (Clontech, Mountain View, CA). DNA sequencing of plasmids confirmed the identity and integrity of the constructs.

Primary ovine fetal turbinate (OFTu) cells were maintained in minimal essential medium (MEM) (Corning; 15010CV) supplemented with 10% fetal bovine serum (FBS) (Atlanta Biologicals, Flowery Branch, GA), 2 mM L-glutamine, gentamicin (50 μg/ml), penicillin (100 IU/ml), and streptomycin (100 μg/ml) [ 15 ]. Human foreskin fibroblast (HFF1) cells (obtained from American Type Culture Collection) were cultured in Iscove Dulbecco’s modified essential medium (IMDM) (Thermo Fischer Scientific; 31980030) supplemented as above. Cells were incubated at 37°C with 5% CO2. ORFV strain OV-IA82 [ 6 ] was used as a parental virus to construct ORFV113 gene deletion virus OV-IA82-Δ113 and for experiments involving wildtype virus infection. OV-IA82-Δ113 was used as parental virus to construct revertant viruses OV-IA82-RV113 Flag (ORFV113 with Flag tag), OV-IA82-RV113 HA (ORFV113 with HA tag) and OV-IA82-RV113 (untagged ORFV113).

All animal procedures were approved by University of Nebraska-Lincoln Institutional Animal Care and Use Committee (IACUC; protocol 1796) and were performed in accordance with the Guide for the Care and Use of Agricultural Animals in Agricultural Research and Teaching.

Results

ORFV113 is a novel ORFV virion protein that is present at early and late times during infection and localizes in the cytoplasm and plasma membrane Parapoxvirus 113 (PPV113) are conserved proteins not found outside the Parapoxvirus genus of the Poxviridae. Proteins are 186 to 238 amino acids in length, with % amino acid identities ranging from 37% to 97%. Comparison with available PPV113 sequences reveals that ORFV strain OV-IA82 ORFV113 shares 81%-97% amino acid identity with ORFV homologues isolated from sheep and goat, 64%-69% with PCPV, 36%-42% with BPSV, 47% with sealpox virus, and 38% with red deerpox virus. OV-IA82 ORFV113 encodes for a protein of 211 amino acids, with predicted molecular weight of 22.2 kDa. ORFV113 lacks homology to known proteins outside the PPV genus, and domains suggestive of protein function. A N terminal transmembrane domain (IA82 positions 6–31) and two predicted N-linked glycosylation sites (IA82 positions 53 and 119) are present in the protein (S1 Fig). The kinetics of ORFV113 expression was assessed during ORFV replication in primary ovine fetal turbinate cells (OFTu) by Western blot using a recombinant virus expressing C-terminally Flag-tagged ORFV113 (OV-IA82-RV113Flag). A protein of approximately 35 kDa was detected starting at 2 h p.i. with increasing protein levels and higher molecular weight species between 35 and 55 kDa observed at later time points (Fig 1A). The observed protein molecular weight was approximately 10 to 25 kDa higher than predicted, suggesting that the protein is post-translationally modified. Under non-reducing PAGE, ORFV113 species greater than 250 kDa were observed, suggesting non-covalent association with itself or other proteins under native conformation (S2 Fig). Consistent with the observation of early expression of ORFV113 by Western blot, ORFV113 transcription was detected early times during ORFV infection (1 to 2 h p.i.) (S3 Fig). ORFV113 transcript level were not affected in the presence of AraC, an inhibitor of DNA replication and of late poxviral gene transcription (S3 Fig). Together, these results indicate that ORFV113 belongs to the early class of poxviral genes. PPT PowerPoint slide

PNG larger image

TIFF original image Download: Fig 1. ORFV113 expression kinetics, presence in virions and supernatants, and subcellular localization. (A) Kinetics of ORFV113 expression. OFTu cells mock infected (M) or infected with revertant virus OV-IA82-RV113Flag (MOI, 10) were harvested at indicated times p.i. Total cell protein extracts were resolved by SDS-PAGE, blotted and incubated with antibodies against Flag and GAPDH. Result is representative of two independent experiments. (B) Detection of ORFV113 in virions. OFTu cells were infected with OV-IA82-Δ113 (Δ113) or OV-IA82-RV113Flag (RV113Flag), and intracellular mature virions (IMV) were purified through double sucrose gradient centrifugation. Whole cell lysate (CL) (50 μg) from OFTu cells mock infected or infected with OV-IA82-RV113Flag, and purified virions (10 μg) were resolved by SDS-PAGE and analyzed by Western blot using antibodies against Flag, structural protein ORFV086 or host GAPDH. Result is representative of three independent experiments. (C and D) Presence of ORFV113 in supernatant of ORFV infected cells and ORFV113 transiently expressing cells. (C) OFTu cells mock infected (M) or infected with OV-IA82-Δ113 or OV-IA82-RV113HA (MOI, 10) were harvested at 24 h p.i. Immunoprecipitation was performed on clarified culture supernatant and immunoprecipitation products were resolved by SDS-PAGE, blotted and incubated with antibodies against HA. Result is representative of two independent experiments. (D) Culture supernatants were harvested from OFTu cells transfected with pCMV-HA (Empty HA plasmid), pCMV-ORFV113HA (ORFV113HA plasmid) or pCMV-ORFV113 (Untagged ORFV113 plasmid) at 24h post transfection. 50 μl of the culture supernatants were resolved by SDS-PAGE, blotted and incubated with antibodies against HA. Result is representative of three independent experiments. # indicates non-specific reactivity with serum protein routinely observed in supernatants. (E) ORFV113 subcellular localization. OFTu cells were mock infected or infected with OV-IA82-RV113HA (MOI, 10), fixed at 1, 3, 6, 9, 12 and 24 h p.i. sequentially incubated with primary antibody against HA and Alexa fluor 488 labeled secondary antibody, counterstained with DAPI and examined by confocal microscopy. https://doi.org/10.1371/journal.ppat.1009971.g001 The presence of ORFV113 in virions was investigated in intracellular mature virions (IMV) purified from OFTu cells infected with an ORFV113 gene deletion virus (OV-IA82-Δ113) or revertant virus expressing Flag tagged ORFV113 (OV-IA82-RV113Flag). Western blot analysis showed a predominant protein band (~35 kDa) and higher molecular weight species (~35 to 55 kDa) corresponding to ORFV113Flag in OV-IA82-RV113Flag virions but not in OV-IA82-Δ113 virions (Fig 1B). The virion core protein ORFV086 was used as a positive control and GAPDH was used as a control for potential cellular contamination. Data indicate that ORFV113 is a virion protein. The presence of ORFV113 in supernatant of ORFV infected cells was investigated. OFTu cells were mock-infected or infected with OV-IA82-Δ113 or OV-IA82-RV113HA for 24 h p.i., supernatants harvested, and immunoprecipitation and western blot performed using anti-HA antibody. ORFV113HA was detected in the supernatant of OV-IA82-RV113HA-infected cells (Fig 1C). To check for the presence of ORFV113 in supernatant of cells transiently expressing ORFV113, OFTu cells were transfected with pCMV-HA (Empty HA plasmid) or pCMV-ORFV113HA (ORFV113HA plasmid) for 24 h, and supernatants harvested, and examined by western blot. Similar to ORFV infected cells supernatant, ORFV113HA was detected in culture supernatant of cells transiently expressing ORFV113 (Fig 1D). Data indicate that ORFV113 is present in supernatant of ORFV infected cells and in cells transiently expressing ORFV113. To examine the subcellular localization of ORFV113, OFTu cells were infected with OV-IA82-RV113HA and examined by confocal microscopy at various times post-infection. ORFV113 staining was observed in paranuclear cytoplasmic region and plasma membrane starting at 3 h p. i. (Fig 1E). Thus, ORFV113 is present at early and late times in infected cells localizing in the cytoplasm and plasma membrane.

ORFV113 is nonessential for ORFV replication in primary OFTu cells but affects ORFV plaque formation Replication kinetics of ORFV113 gene deletion virus (OV-IA82Δ113) was compared with that of revertant virus (OV-IA82-RV113Flag) in OFTu cells. No differences in replication kinetics and viral yields were observed in multi-step and single-step growth curves between the two viruses (Figs 2A, 2B and S4). Plaque assay showed OV-IA82Δ113 plaques were significantly reduced in size (approximately 45% smaller) when compared to OV-IA82-RV113Flag plaques (Fig 2C and 2D). These data suggest that ORFV113 is nonessential for ORFV replication in OFTu cell cultures but affects ORFV plaque formation. PPT PowerPoint slide

PNG larger image

TIFF original image Download: Fig 2. Replication characteristics of ORFV113-gene deletion virus. (A and B) OFTu cells were infected with wildtype OV-IA82 (WT), ORFV113 deletion mutant OV-IA82Δ113 (Δ113) or revertant OV-IA82RV113Flag (RV113) viruses. (A) Single-step growth curve, MOI 10; (B) Multi-step growth curve, MOI 0.1. Titers were determined at indicated times p.i. and expressed as TCID 50 /ml. Results are average of two independent experiments. (C and D) Plaque morphology of ORFV113-gene deletion virus. OFTu cells were infected with OV-IA82Δ113 (Δ113) (GFP reporter) or OV-IA82RV113Flag (RFP reporter) viruses and plaque assay was performed. Shown are representative fluorescent plaque images taken at 5 d p.i. (D) Random plaques were imaged (n = ~100), and plaque area was measured using Nikon A1 software. Relative Δ113 plaque areas compared to RV113 plaques are shown. Results are the average of three independent experiments. Error bars represent mean±SD. Statistical analysis was performed using paired Student’s t-test (**, P<0.01). https://doi.org/10.1371/journal.ppat.1009971.g002

ORFV113 interacts with Lysophosphatidic acid receptor 1(LPA 1 ) ORFV113 is a novel ORFV protein lacking homology with viral and host proteins in the gene bank and motifs suggestive of protein function. A preliminary mass spectrometry experiment using immunoprecipitates from cells transiently expressing ORFV113 identified Lysophosphatidic acid receptor 1, a MAPK p38 activator, as a putative ORFV113 interactor (Mascot score; 15, cut off score 3 at p<0.05) (S5 Fig) [32–35]. To confirm the interaction between ORFV113 and LPA 1 , reciprocal co-immunoprecipitation experiments were performed. OFTu cells co-transfected with control plasmid or pORFV113Flag together with plasmid expressing His tagged LPA 1 (pLPA 1 His) were harvested at 24 h post-transfection and membrane proteins extracted. Reciprocal co-immunoprecipitation was observed following either anti-Flag or anti-His antibody pull downs (Fig 3A). As a control for specificity of ORFV113 and LPA 1 interaction, CD2vHA was used. No interaction was observed between CD2vHA and LPA 1 His in the membrane fraction of the cells expressing both CD2vHA and LPA 1 His (S6 Fig). PPT PowerPoint slide

PNG larger image

TIFF original image Download: Fig 3. ORFV113 interacts with LPA 1 . (A) Co-immunoprecipitation of ORFV113 with LPA 1 . OFTu cells co-transfected with plasmids pcDNA3.1His and pCMVFlag (Empty plasmids) or pcDNA3.1-LPA 1 His (pLPA 1 His) and pCMV-ORFV113Flag (p113Flag) were harvested at 24 h post transfection and membrane fractions were extracted. Membrane lysates (left) and extracts immunoprecipitated with anti-His (upper panel) or anti-Flag (lower panel) antibodies were analyzed by SDS-PAGE-Western blotting with antibodies directed against proteins indicated on the right. * and ** denote light and heavy chain of the IgG antibody, respectively. (B) OFTU cells mock infected or infected with OV-IA82RV113HA for 24 h were fixed and left unpermeabilized, and incubated with primary antibody against HA and LPA 1 , and Alexa Fluor 488 and 647 labeled secondary antibodies, counterstained with DAPI and examined by confocal microscopy. Green; ORFV113HA, Violet; LPA 1 , Blue; DAPI. (C) Skin sections from animals mock infected or infected with OV-IA82RV113HA were processed for immunofluorescence and confocal microscopy as described above. Green; ORFV113HA, Violet; LPA 1 , Blue; DAPI. https://doi.org/10.1371/journal.ppat.1009971.g003 Colocalization of ORFV113 and endogenous LPA 1 was assessed in ORFV infected cells. OFTu cells were mock infected or infected with OV-IA82-RV113HA and fixed at 24h, immunofluorescence was performed using unpermeabilized cells. Colocalization of ORFV113 and LPA 1 was observed in the membrane and paranuclear region of ORFV-infected cells (Fig 3B). Colocalization of ORFV113 and LPA 1 also was examined in skin biopsies of ORFV infected and mock infected sheep. Colocalization of ORFV113 and LPA 1 was observed in areas of ballooned degenerated keratinocytes in the outermost half of epidermis (Fig 3C). Together, data indicate that ORFV113 interacts with LPA 1 in vitro and in vivo.

p38 signaling affects ORFV replication in infected OFTu cells To assess the importance of p38 signaling during ORFV infection, the effect of p38 inhibitor SB203580 on plaque size and ORFV replication was examined. OFTU cells were pretreated with vehicle control (DMSO) or SB203580 for 1 h and infected with OV-IA82-RV113Flag or OV-IA82Δ113, and plaque assay performed in presence of DMSO or SB203580. Cells were fixed at 5 days post infection and fluorescent plaques were imaged (Fig 5A). OV-IA82-RV113Flag plaques size was markedly reduced (82% area reduction) in presence of p38 inhibitor compared with plaques in presence of vehicle control. Significant reduction (45% reduction) was observed in OV-IA82Δ113 plaque size in presence of p38 inhibitor compared to vehicle control, however the effect was less remarkable than that observed for OV-IA82-RV113Flag (Fig 5B). PPT PowerPoint slide

PNG larger image

TIFF original image Download: Fig 5. p38 signaling affects ORFV replication and plaque formation. (A and B) Effect of p38 inhibitor (SB203580) on ORFV plaque size. OFTU cell were pretreated with vehicle control (DMSO) or SB203580 for 1 h and infected with OV-IA82Δ113 (Δ113;GFP reporter) or OV-IA82RV113 (RV113;RFP reporter) and plaque assays were performed in presence of DMSO or SB203580. Shown are representative fluorescent plaque images taken at 5 days p.i. (B) Random plaques were imaged (n = ~100), and plaque areas measured using Nikon A1 software. p38 inhibitor treated Δ113 and RV113 plaques compared to DMSO treated Δ113 and RV113 plaques are shown. Results are average of two independent experiments. Error bars represent mean±SD. Statistical analysis was performed using paired Student’s t-test (*, P<0.05; **, P<0.01). (C) Effect of p38 inhibitor (SB203580) on ORFV replication, OFTU cell pretreated with vehicle control (DMSO) or SB203580 for 1 h were infected with OV-IA82 or OV-IA82Δ113 (MOI:0.1) in presence of DMSO or SB203580. Cultures were harvested at various time points and viral titers determined and expressed as TCID 50 /ml. Results are average of three independent experiments. Error bars represent mean±SD. Statistical analysis was performed using paired Student’s t-test (*, #, P<0.05; **,##, P<0.01). * and # denote statistical significance of DMSO OV-IA82 Vs SB203580 OV-IA82 and DMSO OV-IA82Δ113 Vs SB203580 OV-IA82Δ113, respectively. https://doi.org/10.1371/journal.ppat.1009971.g005 To examine the effect of p38 inhibitor SB203580 on ORFV replication, OFTU cells pretreated with vehicle control (DMSO) or SB203580 for 1 h were infected with OV-IA82 or OV-IA82Δ113 in presence of DMSO or SB203580, harvested at various time points, and titrated. Wildtype virus titers were significantly reduced in presence of p38 inhibitor at 36h (1.5 log), 48h (1.8 log) and 72h (1.7 log) (Fig 5C). Significant reduction was also observed in OV-IA82Δ113 titers in presence of p38 inhibitor at 36h (0.5 log), 48h (1 log) and 72h (1 log), however, the effect was less dramatic compared to OV-IA82 (Fig 5C). Together the plaque assay and growth curve data in the presence of p38 inhibitor indicate that 1- p38 signaling increases ORFV yields, and 2-presence of ORFV113 enhances susceptibility of ORFV to p38 inhibitor effects.

ORFV113 induces p38 phosphorylation in cell transiently expressing ORFV113 and in cells treated with soluble ORFV113 protein To examine the possible effect of ORFV113 alone on p38 phosphorylation, human foreskin fibroblast (HFF-1) cells were untreated, treated with UV for 1 h (positive control), transfected with pCMV-HA (Empty HA plasmid) or plasmid pCMV-ORFV113HA for 2, 4 and 6 h and p38 phosphorylation assessed by western blot. Significantly increased p38 phosphorylation was observed in cells expressing ORFV113 compared to empty plasmid transfected cells at 2h (1.8-fold) and 4h (2.9-fold) post transfection (Fig 6A and 6B). PPT PowerPoint slide

PNG larger image

TIFF original image Download: Fig 6. ORFV113 induces p38 phosphorylation and IL-8 transcription. (A) Expression of ORFV113 induces p38 phosphorylation. HFF1 cells untreated, UV treated or transfected with pCMV-HA (Empty HA plasmid) or pCMV-ORFV113HA (ORFV113HA plasmid) were harvested at respective time points. Total cell protein extracts were resolved by SDS-PAGE, blotted and incubated with antibodies against phos-p38, total p38, HA and GAPDH. (B) Densitometric analysis of bands corresponding to phosphorylated p38. Densitometry of phos-p38 bands were normalized to total p38 (loading control). Results are mean values of four independent experiments. Error bars represent mean±SD. Statistical analysis was performed using paired Student’s t-test (*P < 0.05). (C and D) Expression of ORFV113 induces IL-8 transcription. OFTU cells (C) were transfected with pCMV-HA or pCMV-ORFV113HA for 1, 2 and 3 h and HFF1 cell (D) were transfected for 6h. Levels of IL-8 mRNA were assessed by real-time PCR. Each experiment was performed with biological and technical triplicates. Fold changes are relative to empty HA plasmid treatment. Results are the mean values of three independent experiments. Error bars represent mean±SD. Statistical analysis was performed using paired Student’s t-test (*, P<0.05; **, P<0.01). (E and F) Effect of soluble ORFV113 on p38 activation. (E) OFTu cells were treated with immunoprecipitation product from cells expressing pEmptyHA or pORFV113HA for 1 and 3 h post treatment. Total cell protein extracts were resolved by SDS-PAGE, blotted and incubated with antibodies against phos-p38 and total p38. (F) Densitometric analysis of bands corresponding to phosphorylated p38. Densitometry of phos-p38 bands were normalized to total p38. Results are the average of three independent experiments. Error bars represent mean±SD. Statistical analysis was performed as described in B (*, P<0.05; **, P<0.01). https://doi.org/10.1371/journal.ppat.1009971.g006 To examine downstream gene expression regulated by p38 phosphorylation, OFTu and HFF-1 cells were transfected with pCMV-HA or pCMV-ORFV113HA, and IL-8 transcript levels assessed by RT-PCR. Significantly increased IL-8 transcription was observed in OFTu cells expressing ORFV113 compared to cells transfected with empty plasmid at 2h (4.9-fold) and 3h (6.1-fold) post transfection (Fig 6C) and at 6h (7.7-fold) post transfection in HFF1-cells expressing ORFV113 (Fig 6D). These data indicate that when transfected into cells ORFV113 induces p38 phosphorylation and activates downstream signaling leading to transcriptional activation of IL-8. To investigate the potential effect of ORFV113 present in cell culture supernatant (Fig 1C and 1D) on p38 signaling, OFTu cells were treated with clarified culture supernatants harvested from OFTu cells transfected with pCMV-HA (Empty HA plasmid), pCMV-ORFV113HA (ORFV113HA plasmid) or pCMV-ORFV113 (Untagged ORFV113 plasmid) and phosphorylation of p38 was assessed by Western blot at 3 h post treatment. Treatment of cells with culture supernatants from cells expressing ORFV113HA and Untagged ORFV113 induced significantly higher p38 phosphorylation (3.1 and 5.4 -fold, respectively) compared to control treatment (S8 Fig). To rule out the effect of potential confounding cellular factors present in the culture supernatant on p38 signaling, OFTu cells were treated with immunoprecipitation product from cells expressing pCMV-HA (Empty HA plasmid) or pCMV-ORFV113HA (ORFV113HA plasmid) and phosphorylation of p38 assessed by Western blot at 1 and 3h post treatment. Treatment of cells with ORFV113 immunoprecipitation product induced significantly higher p38 phosphorylation (2.8 and 1.9-fold) compared to control treatment at 1 and 3 h, respectively (Fig 6E and 6F). Together, data indicate that both expression of ORFV113 in cells and treatment of cells with soluble ORFV113 protein induces p38 activation.

LPA 1 is involved in ORFV113 induced p38 phosphorylation in OFTu cells To examine the role of LPA 1 on ORFV113 induced p38 activation, OFTu cells pretreated with DMSO (vehicle control) or LPA 1 inhibitor KI16425 (10 μM) for 45 min were treated with immunoprecipitation products from pCMV-HA or pORFV113HA expressing cells in presence of DMSO or KI16425 (10 μM), harvested at 1 h and 3 h post treatment and processed for Western blot. Significantly increased p38 phosphorylation was observed in vehicle control-treated cells in response to ORFV113 treatment compared to empty vector-treated cells, 1.7 fold at both 1 h and 3 h post treatment. However, no significant difference was observed between ORFV113 treatment compared to empty vector treated cells in presence of KI16425 (Fig 7A and 7B). Data indicate KI16425 inhibits ORFV113 induced p38 phosphorylation. PPT PowerPoint slide

PNG larger image

TIFF original image Download: Fig 7. LPA 1 is involved in ORV113 induced p38 phosphorylation. (A and B) Inhibiton of LPA 1 blocks ORFV113 induced p38 activation. OFTu cells pretreated with DMSO (vehicle control) or KI16425 (LPA 1 inhibitor) (10 μM) for 45 min were treated with immunoprecipitation products from pCMV-HA or pORFV113HA expressing cells in presence of DMSO (vehicle control) or 10 μM KI16425 and harvested at 1 and 3 h post treatment. Total cell protein extracts were resolved by SDS-PAGE, blotted and incubated with antibodies against phos-p38 and total p38. (B) Densitometry of phos-p38 bands were normalized to total p38 (loading control). Results are average of three independent experiments. Error bars represent mean±SD. Statistical analysis was performed using paired Student’s t-test (*, P<0.05; **, P<0.01, NS: non-significant). (C, D and E) Effect of LPA 1 receptor knockdown on ORFV113-induced p38 activation. OFTu cells transfected with universal negative control siRNA (Neg.) or with pooled LPA 1 siRNA (100 nM) for 24 h were either harvested or treated with immunoprecipitation products from pCMV-HA or pORFV113HA expressing cells and harvested at 1 h and 3 h. (C) To measure the LPA 1 knockdown in siRNA-treated cells, total cell protein extracts were resolved by SDS-PAGE, blotted and incubated with antibodies against LPA 1 and GAPDH. Densitometry of LPA 1 bands were normalized to the loading control GAPDH. Approximately 45% LPA 1 knockdown was routinely observed compared to universal negative control siRNA treatment. (D) To assess the effect of siRNA LPA 1 knock down on ORFV113 induced p38 activation, total cell protein extracts were resolved by SDS-PAGE, blotted and incubated with antibodies against phos-p38 and total p38. (E) Densitometry of phos-p38 bands were normalized to the loading control total p38. Results are average of four independent experiments. Error bars represent mean±SD. Statistical analysis was performed as described above (*P < 0.05, NS: non-significant). (F, G and H) Effect of CRISPR LPA 1 receptor knockdown on ORFV113 induced p38 activation. Wild type (WT) and CRISPR knock down (KD) OFTu cells cultured for 16 h were either harvested or treated with immunoprecipitation products from pCMV-HA or pORFV113HA expressing cells and harvested at 1 h and 3 h. (F) LPA 1 knockdown was measured as in C. Approximately 50% LPA 1 knockdown was routinely observed. (G) The effect of LPA 1 knockdown on ORFV113-p38 activation was assessed as in D. (H) Results are average of four independent experiments. Error bars represent mean±SD. Statistical analysis was performed as described above (*, P<0.05; **, P<0.01, NS: non-significant). https://doi.org/10.1371/journal.ppat.1009971.g007 To assess the effect of LPA 1 knockdown on ORFV113 induced p38 phosphorylation, OFTu cells were transfected with negative control siRNA or pooled LPA 1 siRNA for 24 h. Cells were either harvested or treated with immunoprecipitation products from pCMV-HA or pORFV113HA expressing cells, and p38 phosphorylation was assessed at 1 and 3 h post treatment by Western blot. Approximately 45% reduction in LPA 1 routinely was observed in knock down cells (Fig 7C). Significantly increased p38 phosphorylation was observed in negative control siRNA transfected cells in response to ORFV113 treatment compared to empty vector treated cells (1.4 and 1.3-fold at 1 h and 3 h post treatment, respectively). However, no significant difference was observed between ORFV113 treatment compared to empty vector treated cells in LPA 1 siRNA transfected cells (Fig 7D and 7E). To further examine the effect of LPA 1 knockdown on ORFV113 induced p38 phosphorylation, LPA 1 knock down OFTu cells were obtained using CRISPR. Wild-type and CRISPR LPA 1 knockdown OFTu cells were treated with immunoprecipitation products from pCMV-HA or pORFV113HA expressing cells, harvested at 1 h and 3 h post treatment and assessed for p38 phosphorylation by Western blot. Approximately 50% reduction in LPA 1 was routinely observed in knockdown cells (Fig 7F). Significantly increased p38 phosphorylation was observed in wild-type OFTu cells in response to ORFV113 treatment compared to empty vector treated cells (2 and 1.5-fold at 1 h and 3 h post treatment, respectively). However, no significant difference was observed between ORFV113 and empty vector treatment in LPA 1 knockdown cells (Fig 7G and 7H). Together, these data suggest that LPA 1 in cells inhibits p38 phosphorylation and binding of ORFV113 to LPA 1 neutralizes its inhibitory function leading to increased p38 phosphorylation in cells mimicking that observed with KI16425 inhibition.

Treatment with LPA and antibody against LPA 1 enhances ORFV113 induced p38 phosphorylation in OFTu cells Results above indicate that LPA 1 is involved in ORFV113 induced p38 phosphorylation. Several studies have shown that LPA induces p38 phosphorylation in different cell types [32–35]. In the skin, LPA levels increase in response to tissue injury and induces multiple signaling pathways including the p38 pathway [50]. Thus, a potential role of LPA in ORFV113-induced p38 signaling in natural infection can be hypothesized. To examine the effect of LPA on ORFV113-induced p38 signaling, OFTu cells transfected with plasmids pCMV-HA or pCMV-ORFV113HA for 5 h were treated with LPA for 5, 10 or 20 min, harvested and processed for western blot. In cells transfected with control plasmids, significantly increased p38 phosphorylation was observed in cells treated with LPA for 5 min (1.8-fold) compared to untreated cells. Significantly increased p38 phosphorylation was observed in ORFV113 expressing cells treated with LPA for 20 min (1.6 -fold) compared to untreated cells (Fig 8A and 8B). Data indicate that LPA enhances ORFV113-induced p38 signaling. PPT PowerPoint slide

PNG larger image

TIFF original image Download: Fig 8. Treatment with LPA and antibody against LPA 1 enhances ORFV113 induced p38 phosphorylation. (A and B) LPA treatment enhances ORFV113 induced p38 phosphorylation. OFTu cells transfected with plasmids pCMV-HA or pORFV113HA for 5 h were induced with LPA harvested at 5, 10 and 20 min. Total cell protein extracts were resolved by SDS-PAGE, blotted and incubated with antibodies against phos-p38, total p38, HA and GAPDH. (B) Densitometry of phos-p38 bands were normalized to total p38 (loading control). Results are average of four independent experiments. Error bars represent mean±SD. Statistical analysis was performed using one-way ANOVA with post hoc Tukey test for multiple comparisons (*, P<0.05; **, P<0.01, NS: non-significant). (C and D) Antibody against LPA 1 enhances ORFV113 induced p38 phosphorylation. OFTu cells pretreated with isotype control or LPA 1 monoclonal antibody (10 μg/ml) for 45 min were treated with immunoprecipitation products from pCMV-HA or pORFV113HA expressing cells in presence of isotype control or LPA 1 monoclonal antibody (10 μg/ml) and harvested at 1 and 3 h. Total cell protein extracts were resolved by SDS-PAGE, blotted and incubated with antibodies against phos-p38 and total p38. (D) Densitometry of phos-p38 bands were normalized as in B. Results are average of five independent experiments. Error bars represent mean ±SD. Statistical analysis was performed as described in B (*,#, P<0.05; **, P<0.01; NS: non-significant). https://doi.org/10.1371/journal.ppat.1009971.g008 To assess the involvement of LPA 1 on ORFV113 induced p38 phosphorylation, OFTu cells pretreated with isotype control or LPA 1 monoclonal antibody for 45 min were treated with immunoprecipitation products from pCMV-HA or pORFV113HA expressing cells in presence of antibodies and harvested at 1 h and 3 h, and processed for Western blot. Treatment with antibody against LPA 1 and with ORFV113 significantly increased p38 phosphorylation compared to isotype control/ORFV113 treated cells at 1 h post treatment (1.5-fold) (Fig 8C and 8D). Data suggests that treatment with antibody against LPA 1 enhances ORFV113 induced p38 phosphorylation.

[END]

[1] Url: https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009971

(C) Plos One. "Accelerating the publication of peer-reviewed science."
Licensed under Creative Commons Attribution (CC BY 4.0)
URL: https://creativecommons.org/licenses/by/4.0/


via Magical.Fish Gopher News Feeds:
gopher://magical.fish/1/feeds/news/plosone/

You are viewing proxied material from magical.fish. The copyright of proxied material belongs to its original authors. Any comments or complaints in relation to proxied material should be directed to the original authors of the content concerned. Please see the disclaimer for more details.